Summary
Duluth, Ga., July 25, 2017 – Sebacia, Inc., a privately held, clinical and commercial stage dermatologyand aesthetics company, today announced that the company has completed a $20 million Series Dfinancing led by existing investors Versant Ventures, Domain Associates, Accuitive Medical Ventures and Partners Healthcare Innovation Fund. New investors accounted for approximately 60 percent of theround and include Salem Partners and other undisclosed investors. Additionally, Sebacia closed a $16million debt facility with Hercules Capital.
Click Here
to read the full article
Click Here
to read the full article